A DAILY pill that can double pancreatic cancer survival time is the biggest breakthrough in decades, say doctors treating the disease. Terminal patients who took daraxonrasib were three times more likely to still be alive after a year. Their chance of survival increased from 17.3 per cent to 53.2 per cent. They lived twice as...